TFA Therapeutics (RAJAF) Income from Continuing Operations (2020 - 2023)
TFA Therapeutics (RAJAF) posted Income from Continuing Operations of $83430.0 for Q4 2023, up 326.15% on a QoQ basis from -$36891.0 in Q4 2022, and up 326.15% year-over-year from $19577.5 in Q4 2022.
Powered by 
Analysis
TFA Therapeutics (RAJAF) Income from Continuing Operations (2020 - 2023) Analysis & Trends
TFA Therapeutics has reported Income from Continuing Operations for 3 years, with the latest figure at $83430.0 in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 69.71 Bn | 68.67 Bn | 3.30 Bn | 719.00 Mn |
| 2 | Kenvue | 34.22 Bn | 33.11 Bn | 2.30 Bn | 456.00 Mn |
| 3 | Kimberly Clark | 32.55 Bn | 31.72 Bn | 1.60 Bn | 355.00 Mn |
| 4 | Bath & Body Works | 3.52 Bn | 2.73 Bn | 692.00 Mn | 118.00 Mn |
| 5 | Prestige Consumer Healthcare | 2.52 Bn | 2.46 Bn | - | - |
| 6 | Perrigo | 1.88 Bn | 1.49 Bn | 313.90 Mn | 88.50 Mn |
| 7 | Edgewell Personal Care | 1.25 Bn | 854.93 Mn | 242.50 Mn | 12.30 Mn |
| 8 | Herbalife | 1.25 Bn | 883.17 Mn | 1.03 Bn | -26.50 Mn |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | - |
| 10 | Honest Company | 611.15 Mn | 505.26 Mn | 40.36 Mn | 10.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 83,430.00 |
| Dec 31, 2022 | -36,891.00 |
| Dec 31, 2020 | -13,476.00 |